Brief: Akoustis Technologies Inc Expects Revenue For Three Months Ended Dec 31 To Be About $5.9 Mln
18/01/2023 22:47
Jan 18 (Reuters) - Akoustis Technologies Inc AKTS.O :
* AKOUSTIS TECHNOLOGIES INC - EXPECT REVENUE FOR THE THREE
MONTHS
ENDED DECEMBER 31, 2022 TO BE APPROXIMATELY $5.9 MILLION
Source: (shorturl.at/fMPR1)
Further company coverage: AKTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aktis Oncology
See all newsAktis Oncology Q2 net loss widens on higher R&D, administrative costs
U.S. RESEARCH ROUNDUP-Danaher, GM, MSCI
Aktis Oncology Q1 net loss widens on increased IPO-related expenses
Generate Biomedicines shares fall 6% in weak Nasdaq debut for drug developer (updated)
Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut